FDA Clearance Tracker · DEN210024
CavaClear Laser Sheath
Last checked: Nov 20, 2026Latest source record: Dec 21, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2021
De Novo granted
Time to decision
179 days
Received Jun 25, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN210024
- Device name
- CavaClear Laser Sheath
- Applicant
- Spectranetics, Inc.
- Applicant location
- Colorado Springs, CO
- Received
- Jun 25, 2021
- Decided
- Dec 21, 2021
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.5125
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN210024
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Spectranetics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223472 · Decided Dec 15, 2022 · 28 days after receipt
Device type: Dilator, Vessel, For Percutaneous Catheterization (DRE) · Cardiology
- Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters510(k)
K222837 · Decided Dec 8, 2022 · 79 days after receipt
Device type: Catheter, Peripheral, Atherectomy (MCW) · Cardiology
K212784 · Decided Aug 24, 2022 · 357 days after receipt
Device type: Dilator, Vessel, For Percutaneous Catheterization (DRE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.